Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Effects of glucosamine hydrochloride and chondroitin sulphate, alone and in combination, on normal and interleukin‐1 conditioned equine articular cartilage explant metabolism

Effects of glucosamine hydrochloride and chondroitin sulphate, alone and in combination, on... Summary Reasons for performing study: Clinical trials in human and veterinary literature have documented the benefits of oral nutraceutical joint supplements containing glucosamine (GU) and chondroitin sulphate (CS) to treat mild to moderate osteoarthritis, but the effects of these components have not yet been conclusively determined. Objectives: To assess varying dosages of GU and CS on normal and interleukin‐1α (IL‐1) conditioned equine cartilage explants and rationalise the use of these products. Hypothesis: Treatment would not be detrimental to cartilage metabolism and higher dosages and the combination of GU and CS would be more beneficial than lower dosages and GU or CS alone. Methods: Articular cartilage explants collected from the femoral trochlea and condyles were cultured in normal and IL‐1 conditioned media. Treatment groups included 0, 12.5, 25, 125 and 250 μg/ml concentrations of GU alone, CS alone, or GU+CS in combination. Glycosaminoglycan (GAG) synthesis and total GAG content in the explants and media were analysed. Results: There were no detrimental effects of GU, CS or GU+CS on cartilage metabolism. High dosages of GU+CS reduced total GAG release into the media (degradation). Conclusions: Our results suggests that GU+CS may prevent cartilage GAG degradation. Potential relevance: The combination of GU and CS may be more effective in preventing or treating osteoarthritis in horses than either product alone. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Equine Veterinary Journal Wiley

Effects of glucosamine hydrochloride and chondroitin sulphate, alone and in combination, on normal and interleukin‐1 conditioned equine articular cartilage explant metabolism

Download PDF
5 pages

Loading next page...
 
/lp/wiley/effects-of-glucosamine-hydrochloride-and-chondroitin-sulphate-alone-PdNCleYIp3
Publisher
Wiley
Copyright
2005 EVJ Ltd
ISSN
0425-1644
eISSN
2042-3306
DOI
10.2746/0425164054530687
Publisher site
See Article on Publisher Site

Abstract

Summary Reasons for performing study: Clinical trials in human and veterinary literature have documented the benefits of oral nutraceutical joint supplements containing glucosamine (GU) and chondroitin sulphate (CS) to treat mild to moderate osteoarthritis, but the effects of these components have not yet been conclusively determined. Objectives: To assess varying dosages of GU and CS on normal and interleukin‐1α (IL‐1) conditioned equine cartilage explants and rationalise the use of these products. Hypothesis: Treatment would not be detrimental to cartilage metabolism and higher dosages and the combination of GU and CS would be more beneficial than lower dosages and GU or CS alone. Methods: Articular cartilage explants collected from the femoral trochlea and condyles were cultured in normal and IL‐1 conditioned media. Treatment groups included 0, 12.5, 25, 125 and 250 μg/ml concentrations of GU alone, CS alone, or GU+CS in combination. Glycosaminoglycan (GAG) synthesis and total GAG content in the explants and media were analysed. Results: There were no detrimental effects of GU, CS or GU+CS on cartilage metabolism. High dosages of GU+CS reduced total GAG release into the media (degradation). Conclusions: Our results suggests that GU+CS may prevent cartilage GAG degradation. Potential relevance: The combination of GU and CS may be more effective in preventing or treating osteoarthritis in horses than either product alone.

Journal

Equine Veterinary Journal – Wiley

Published: May 1, 2005

References

  • The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulphate after single and multiple doses to beagle dogs
    Adebowale, Adebowale; Du, Du; Liang, Liang; Leslie, Leslie; Eddington, Eddington
  • In vitro effects of glucosamine and acetylsalicylate on canine chondrocytes in 3‐dimensional culture
    Anderson, Anderson; Cook, Cook; Kreeger, Kreeger; Tomlinson, Tomlinson; Wagner‐Mann, Wagner‐Mann
  • Effects of chondroitin sulphate and interleukin‐1β (beta) on human articular chondrocytes cultivated in clusters
    Bassleer, Bassleer; Combal, Combal; Bougaret, Bougaret; Malaise, Malaise
  • Stimulation of proteoglycan production by glucosamine sulphate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro
    Bassleer, Bassleer; Rovatti, Rovatti; Franchimoni, Franchimoni
  • Correlation between radiographic severity of knee osteoarthritis and future disease progression. Results from a 3‐year prospective, placebo‐controlled study evaluating the effect of glucosamine sulphate
    Bruyere, Bruyere; Honore, Honore; Ethgen, Ethgen; Rovati, Rovati; Giacovelli, Giacovelli; Henroitin, Henroitin; Seidel, Seidel; Reginster, Reginster
  • Influence of glucosamine on matrix metalloproteinase expression and activity in lipopolysaccharide‐stimulated equine chondrocytes
    Byron, Byron; Orth, Orth; Venta, Venta; Lloyd, Lloyd; Caron, Caron
  • Hormesis: the dose‐response revolution
    Calabrese, Calabrese; Baldwin, Baldwin
  • Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulphate and manganese ascorbate in the management of knee osteoarthritis
    Das, Das; Hammad, Hammad
  • Glucosamine and chondroitin sulphate
    Davidson, Davidson
  • High doses of glucosamine‐HCl have detrimental effects on bovine articular cartilage explants cultured in vitro
    Mattei, Mattei; Pellati, Pellati; Pasello, Pasello; Terlizzi, Terlizzi; Massari, Massari; Gemmati, Gemmati; Caruso, Caruso
  • Effects of dosage titration of methylprednisolone acetate and triamcinolone acetonide on interleukin 1‐conditioned equine articular cartilage explants in vitro
    Dechant, Dechant; Baxter, Baxter; Frisbie, Frisbie; Trotter, Trotter; McIlwraith, McIlwraith
  • The fate of oral glucosamine traced by 13C‐labelling in the dog
    Dodge, Dodge; Regatte, Regatte; Hall, Hall; Borthakur, Borthakur; Sarma, Sarma; Callaway, Callaway; Reddf, Reddf
  • The bioavailability and pharmacokinetics of glucosamine hydrochloride and chondroitin sulphate after oral and intravenous single dose administration in the horse
    Du, Du; White, White; Eddingon, Eddingon
  • Evidence of the oral absorption of chondroitin sulphate as determined by total disaccharide content after oral and intravenous administration to horses
    Eddington, Eddington; Du, Du; White, White
  • A direct spectrophotometric microassay for sulphated glycosaminoglycans in cartilage cultures
    Farndale, Farndale; Sayers, Sayers; Barrett, Barrett
  • Effect of glucosamine on interleukin‐1‐conditioned articular cartilage
    Fenton, Fenton; Chlebek‐Brown, Chlebek‐Brown; Caron, Caron; Orth, Orth
  • Glucosamine HCl reduces equine articular cartilage degradation in explant culture
    Fenton, Fenton; Chlebek‐Brown, Chlebek‐Brown; Peters, Peters; Caron, Caron; Orth, Orth
  • The assessment of chondrocyte proteoglycan metabolism using molecular sieve column chromatography as compared to three commonly utilized techniques
    Frisbie, Frisbie; Kawcak, Kawcak; Trotter, Trotter; McIlwraith, McIlwraith
  • Metabolic and mitogenic activities of insulin‐like growth factor‐1 in interleukin‐1‐conditioned equine cartilage
    Frisbie, Frisbie; Sandler, Sandler; Trotter, Trotter; McIlwraith, McIlwraith
  • Polysulphated glycosaminoglycan accelerates net synthesis of collagen and glycosaminoglycans by arthritic equine cartilage tissue and chondrocytes
    Glade, Glade
  • Chondroprotective and gene expression effects of nutritional supplements on articular cartilage
    Grande, Grande; O'Grady, O'Grady; Garone, Garone; Lippiello, Lippiello; Marwin, Marwin
  • Glucosamine modulates IL‐1‐induced activation of rat chondrocytes at a receptor level, and by inhibiting the NF‐*kB pathway
    Gouze, Gouze; Bianchi, Bianchi; Becuwe, Becuwe; Dauca, Dauca; Netter, Netter; Magdalou, Magdalou; Terlain, Terlain; Bordji, Bordji
  • Oral treatment with a nutraceutical (Cosequin) for ameliorating signs of navicular syndrome in horses
    Hanson, Hanson; Brawner, Brawner; Blaik, Blaik; Hammad, Hammad; Kincaid, Kincaid; Pugh, Pugh
  • Oral treatment with a glucosamine‐chondroitin sulphate compound for degenerative joint disease in horses: 25 cases
    Hanson, Hanson; Smalley, Smalley; Huff, Huff; White, White; Hammad, Hammad
  • Glucosamine inhibits IL‐1β‐induced NF*kB activation in human osteoarthritic chondrocytes
    Largo, Largo; Alvarez‐Soria, Alvarez‐Soria; Diez‐Ortego, Diez‐Ortego; Clavo, Clavo; Sanchez‐Pernaute, Sanchez‐Pernaute; Edigo, Edigo; Herrero‐Beaumont, Herrero‐Beaumont
  • Glucosamine and chondroitin sulphate: biological response modifiers of chondrocytes under simulated conditions of joint stress
    Lippiello, Lippiello
  • Protective effect of the chondroprotective agent Cosequin DS on bovine articular cartilage exposed in vitro to nonsteroidal anti‐inflammatory agents
    Lippiello, Lippiello; Han, Han; Henderson, Henderson
  • In vivo chondroprotection and metabolic synergy of glucosamine and chondroitin sulphate
    Lippiello, Lippiello; Woodward, Woodward; Karpman, Karpman; Hammad, Hammad
  • Regulation of matrix metabolism in equine cartilage explant cultures by interleukin‐1
    MacDonald, MacDonald; Stover, Stover; Willits, Willits; Benton, Benton
  • Quantification of 35S‐labeled proteoglycans complexed to alcian blue by rapid filtration in multiwell plates
    Masuda, Masuda; Shirota, Shirota; Thonar, Thonar
  • Glucosamine and chondroitin for treatment of osteoarthritis ‐ a systematic quality assessment and meta‐analysis
    McAlindon, McAlindon; LaValley, LaValley; Gulin, Gulin; Felson, Felson
  • Clinical evaluation of a nutraceutical, carprofen and meloxicam for the treatment of dogs with osteoarthritis
    Moreau, Moreau; Dupuis, Dupuis; Bonneau, Bonneau; Desnoyers, Desnoyers
  • Effects of (3H) glucosamine concentration on (3H) chondroitin sulphate formation by cultured chondrocytes
    Mroz, Mroz; Silbert, Silbert
  • Effects of chondroitin sulphate and interleukin‐1β on human chondrocyte cultures exposed to pressurization: a biochemical and morphological study
    Nerucci, Nerucci; Fioravanti, Fioravanti; Cicero, Cicero; Collodel, Collodel; Marcolongo, Marcolongo
  • Inhibition of articular cartilage degradation by glucosamine‐HCl and chondroitin sulphate
    Orth, Orth; Peters, Peters; Hawkins, Hawkins
  • An investigation of the proteglycan metabolism of mature equine articular cartilage and its regulation by interleukin‐1
    Platt, Platt; Bayliss, Bayliss
  • Long‐term effects of glucosamine sulphate on osteoarthritis progression: a randomized, placebo‐controlled clinical trial
    Reginster, Reginster; Deroisy, Deroisy; Rovati, Rovati; Lee, Lee; Lejeune, Lejeune; Bruyere, Bruyere; Giacovelli, Giacovelli; Henroitin, Henroitin; Dacre, Dacre; Gossett, Gossett
  • Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis
    Richy, Richy; Bruyere, Bruyere; Ethgen, Ethgen; Cucherat, Cucherat; Henroitin, Henroitin; Reginster, Reginster
  • Anti‐inflammatory activity of chondroitin sulphate
    Ronca, Ronca; Palmieri, Palmieri; Panicucci, Panicucci; Ronca, Ronca
  • A dose titration of triamcinolone acetonide on insulin‐like growth factor‐1 and interleukin‐1‐conditioned equine cartilage explants
    Sandler, Sandler; Frisbie, Frisbie; McIlwraith, McIlwraith
  • Chondrocyte‐mediated catabolism of aggrecan: aggrecanase‐dependent cleavage induced by interleukin‐1 or retinoic acid can be inhibited by glucosamine
    Sandy, Sandy; Gamett, Gamett; Thompson, Thompson; Verscharen, Verscharen
  • Absorption, distribution, metabolism and excretion of glucosamine sulphate. A review
    Setnikar, Setnikar; Rovati, Rovati
  • Systems to assess the progression of finger joint osteoarthritis and the effects of disease modifying osteoarthritis drugs
    Verbruggen, Verbruggen; Goemaere, Goemaere; Veys, Veys
  • Oral supplement in the treatment and prevention of joint diseases: a review of their potential application to the horse
    Wright, Wright